γ′ Fibrinogen: Evaluation of a New Assay for Study of Associations with Cardiovascular Disease
Open Access
- 1 May 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 56 (5), 781-788
- https://doi.org/10.1373/clinchem.2009.138347
Abstract
Background: Studies of disease associations with γ′ fibrinogen, a newly emerging risk factor for cardiovascular disease, have been hampered by the lack of a standardized and well-characterized assay. Methods: We developed an immunometric technique to measure γ′ fibrinogen concentrations in plasma and studied the clinical utility of this test in samples from healthy individuals enrolled in the Framingham Offspring Study and in a separate case/control study of coronary artery disease (CAD). Monoclonal antibody 2.G2.H9, specific for the unique carboxyl terminal peptide of the fibrinogen γ′ chain, was used as capture antibody. Sheep antihuman fibrinogen/horseradish peroxidase conjugate was used for detection, with 3,3′,5,5′-tetramethylbenzidine as substrate. We evaluated the linearity, imprecision, analytical specificity, and lower limit of quantification of the assay. We determined the reference interval for γ′ fibrinogen in healthy individuals from the Framingham Offspring Study (n = 2879) and quantified associations between γ′ fibrinogen and cardiovascular disease risk factors. The sensitivity and specificity of γ′ fibrinogen in evaluating CAD patients (n = 133) was determined with ROC curve analysis. Results: The γ′ fibrinogen ELISA had within-run CVs of 13.4% at 0.127 g/L and 4.8% at 0.416 g/L. The limit of quantification at an imprecision of 20% was 0.10 g/L. The reference interval for healthy individuals was 0.088–0.551 g/L. ROC curve analysis of results from patients with CAD yielded an area under the curve of 0.76, with a diagnostic accuracy of 0.78 at a decision threshold of 0.30 g/L. Conclusions: γ′ Fibrinogen shows excellent utility for cardiovascular risk analysis.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (N01-HC-25195, R21-HL-75006, R21-HL-97298)
- American Heart Association (0865486G)
- NIH (N000140610411)
- Office of Naval Research
This publication has 29 references indexed in Scilit:
- The presence of γ′ chain impairs fibrin polymerizationThrombosis Research, 2009
- Fibrinogen γ′ in Ischemic StrokeStroke, 2008
- Associations of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies: The Fibrinogen Studies CollaborationAmerican Journal of Epidemiology, 2007
- Elevated plasma fibrinogen γ′ concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factorsJournal of Thrombosis and Haemostasis, 2007
- Conformational Analysis of γ‘ Peptide (410−427) Interactions with Thrombin Anion Binding Exosite IIBiochemistry, 2006
- Fibrinogen gamma-chain splice variant γ′ alters fibrin formation and structureBlood, 2003
- Evidence That Both Exosites on Thrombin Participate in Its High Affinity Interaction with FibrinPublished by Elsevier BV ,2003
- Fibrinogen γ′ chain binds thrombin exosite IIJournal of Thrombosis and Haemostasis, 2003
- Resistance of γA/γ′ Fibrin Clots to FibrinolysisPublished by Elsevier BV ,1997
- .gamma. and .gamma.' chains of human fibrinogen are produced by alternative mRNA processingBiochemistry, 1984